MedTrace Logo

Noninvasive Mapping Before Surgical Ablation

NCT06803615 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2025-06-29

No results posted yet for this study

Summary

The purpose of this study is to assess the electrophysiological mechanism of atrial fibrillation by means of a beat-to-beat noninvasive 3D mapping method in patients with concomitant persistent and long-standing persistent atrial fibrillation undergoing surgical ablation.

Conditions

  • Atrial Fibrillation (AF)

Interventions

DEVICE

Electrocardiographic imaging

Electrocardiographic imaging is an electrophysiological mapping technique which is used to noninvasively map cardiac arrhythmias.

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Emilio Osorio, MD · Medical University of Vienna

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-13
Primary Completion
2024-01-01
Completion
2026-01-31
FDA Device
Yes

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06803615 on ClinicalTrials.gov